| Literature DB >> 28586373 |
Hua Zheng1,2, Alexander Schnabel2,3, Maryam Yahiaoui-Doktor4, Winfried Meissner5, Hugo Van Aken2, Peter Zahn6, Esther Pogatzki-Zahn2.
Abstract
OBJECTIVES: Current literature is in disagreement regarding female sex as a risk factor for pain after surgery. We hypothesized, that sex differences exist but that they are influenced by certain factors. Here, we investigated the influence of sex for different clinically relevant postoperative pain (POP) outcome parameters and evaluated the role of assumed confounders for sex differences.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28586373 PMCID: PMC5460859 DOI: 10.1371/journal.pone.0178659
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Details of postoperative management including a continuous regional anesthetic technique.
| Analgesic Technique | Drugs applied | Basal infusion rate | Demand Dose | Lockout-Interval |
|---|---|---|---|---|
| Ropivacaine 0.2% or bupivacaine 0.175% + Sufentanil 0.175 μg/ml (for patients <70 yr and without chronic opioid medication) | 5 ml/h | 2 ml | 20 min | |
| Bupivacaine 0.175% | Weight based manner (Half of max. recommended dose (0.4mg/kg KG) as basal infusion rate, other half as two possible boli within one hour) | 30 min | ||
| Ropivacaine 0.2% | Weight based manner (Half of max. recommended dose (0.5mg/kg KG) as basal infusion rate, other half as two possible boli within one hour) | 30 min | ||
Fig 1Patient flow during enrollment and analysis.
Demographic data (as n (%)).
| Women (n = 403) | Men (n = 487) | p Value | |
|---|---|---|---|
| 176(39.6%) | 269(60.4%) | <0.001 | |
| 226(50.9%) | 218(49.1%) | ||
| 275 (52.0%) | 254 (48.0%) | <0.001 | |
| 122(34.8%) | 229(65.2%) | ||
| Bone surgery | 154 (46.7%) | 176 (53.3%) | 0.214 |
| Joint surgery | 189 (46.6%) | 217 (53.4%) | |
| Soft tissue surgery | 59 (38.8%) | 93 (61.2%) | |
| General anesthesia | 274 (44.9%) | 336 (55.1%) | 0.248 |
| Regional anesthesia | 34 (39.5%) | 52 (60.5%) | |
| General and regional anesthesia | 90 (50.0%) | 90 (50.0%) |
Sex related differences were compared with χ2 Test.
Results of the linear regression analysis investigating possible predictors for worst postoperative pain since surgery.
| Predictor Variable | p—Value | β | Lower bound | Upper bound |
|---|---|---|---|---|
| -0.176 | -0.714 | -0.319 | ||
| 0.157 | 0.493 | 1.249 | ||
| -0.095 | -0.888 | -0.158 | ||
| -0.072 | -0.568 | -0.029 | ||
| 0.261 | Could not be included in model | |||
¥ grouped in 20 year intervals, in increasing order
ª Reference category is “male”
* GA and GA + RA compared to RA only
Results of the ANOVA investigating the interaction of the factors “age”, “preoperative pain”, “anesthetic technique” and “surgical procedure” with sex differences of the outcome “worst postoperative pain since surgery”.
| Explanatory Factor | P value | |
|---|---|---|
| Females | Males | |
| 0.282 | ||
| 0.532 | 0.087 | |
| 0.557 | 0.964 | |
| 0.684 | 0.076 | |
| 0.420 | 0.053 | |
*up to 50 years old compared with 50+
#compared with RA only
Δcompared with soft-tissue surgery
Results of sex differences in postoperative pain outcome and subgroup analysis focusing on the influence of age and preoperative pain.
| Outcome | Sex | All Groups | Age Groups | Preoperative Pain Groups | ||
|---|---|---|---|---|---|---|
| <50 years | ≥50 years | with | without | |||
| Women | 5.75 ± 2.61 | 5.85 ± 2.59 | 5.68 ± 2.85 | 5.97 ± 2.72 | 5.24 ± 2.71 | |
| Men | 5.20 ± 2.70 | 5.58 ± 2.61 | 4.72 ± 2.73 | 5.50 ± 2.60 | 4.89 ± 2.78 | |
| Women | 34% ± 25% | 34% ± 24% | 34% ± 26% | 37% ± 26% | 27% ± 23% | |
| Men | 27% ± 23% | 27% ± 23% | 26% ± 22% | 29% ± 23% | 24% ± 22% | |
| Women | 4.65 ± 2.83 | 4.68 ± 2.83 | 4.64 ± 2.83 | 4.97 ± 2.71 | 3.92 ± 2.98 | |
| Men | 4.38 ± 2.83 | 4.81 ± 2.82 | 3.85 ± 2.76 | 4.75 ± 2.73 | 3.98 ± 2.91 | |
| Women | 2.66 ± 2.53 | 2.69 ± 2.49 | 2.65 ± 2.57 | 2.98 ± 2.60 | 1.90 ± 2.17 | |
| Men | 2.18 ± 2.39 | 2.30 ± 2.44 | 2.04 ± 2.33 | 2.58 ± 2.46 | 1.73 ± 2.22 | |
| Women | 3.13 ± 3.05 | 3.01 ± 2.95 | 3.24 ± 3.14 | 3.59 ± 3.20 | 2.12 ± 2.44 | |
| Men | 2.31 ± 2.66 | 2.37 ± 2.69 | 2.23 ± 2.63 | 2.74 ± 2.78 | 1.81 ± 2.43 | |
| Women | 0.39 ± 0.50 | 0.39 ± 0.48 | 0.39 ± 0.51 | 0.45 ± 0.55 | 0.25 ± 0.34 | |
| Men | 0.31 ± 0.41 | 0.36 ± 0.44 | 0.24 ± 0.37 | 0.32 ± 0.42 | 0.30 ± 0.41 | |
| Women | 62% ± 26% | 66% ± 24% | 59% ± 27% | 59% ± 26% | 69% ± 26% | |
| Men | 62% ± 28% | 60% ± 28% | 64% ± 27% | 59% ± 27% | 64% ± 28% | |
| Women | 19% (72/388) | 22% (37/169) | 16% (35/218) | 22% (58/267) | 11% (13/117) | |
| Men | 17% (80/471) | 19% (48/260) | 15% (32/211) | 20% (49/244) | 14% (31/225) | |
| Women | 7.62 ± 2.75 | 7.62 ± 2.60 | 7.60 ± 2.88 | 7.49 ± 2.77 | 7.96 ± 2.69 | |
| Men | 7.53 ± 2.79 | 7.47 ± 2.61 | 7.61 ± 3.01 | 7.34 ± 2.93 | 7.74 ± 2.62 | |
Results are presented as mean (± standard deviation) or relative numbers (% (n/N)). Groups were compared using Mann-Whitney U Test or χ2 Test (“wish for more treatment”).
* P<0.05 women vs. men